The Children's Hospital of Pittsburgh (CHP) is the pediatric cancer center for western Pennsylvania, northern West Virginia, and eastern Ohio. We are a multidisciplinary pediatric oncology team with 6 chemotherapists, 2 radiation oncologists, 4 pathologists, 5 surgeons (including 1 neuro- and 1 orthopedic surgeon), 1 radiologist, and a support team which includes nurse specialists, a social worker, psychiatric liaison, data managers, and secretarial support. Our primary aims over the past two years have been increased participation in the Children's Cancer Study Group (CCSG) through increased patient accrual and increased committee involvement, as well as development of a laboratory and clinical research base. Our particular interests in the laboratory have been focused on 2 areas: i) hormonal interactions with cancer cells, which we are studying in collaboration with the division of endocrinology at Children's Hospital of Pittsburgh; ii) identification of histochemical and immunologic markers for a variety of solid tumors. Clinically, our primary thrust has been in the area of late effects of cancer therapy. For example, in an ongoing study, preliminary results suggest that children with leukemia who have received 2400r cranial radiation have reduced spontaneous pulsatile secretion of growth hormone, a finding which may in part be responsible for the short stature which has been observed in these patients. In another prospective study, which is in progress, we are looking at the effect of testicular relapse of leukemia on testicular endocrine function. The results of these studies will be important in designing new therapeutic regimens with fewer late effects. Other areas of ongoing and planned clinical investigation include complications of broviac catheters, and experimental chemotherapy (e.g., deoxycoformycin). We plan over the next 5 years to pursue these areas both as a part of CCSG and as an independent organization. Our own studies will be done with non-CCSG funding but will utilize our CCSG protocol patients with the goal of accruing data which ultimately will be of benefit to the entire Group. To facilitate these plans we anticipate recruiting additional faculty, computerizing our data base and tumor registry, as well as acquisition of more space as a result of the current expansion of the Children's Hospital of Pittsburgh.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA036015-04
Application #
3557878
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1984-02-01
Project End
1988-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
4
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Children's Hosp Pittsburgh/Upmc Health Sys
Department
Type
DUNS #
044304145
City
Pittsburgh
State
PA
Country
United States
Zip Code
15224
Neudorf, Steven; Sanders, Jean; Kobrinsky, Nathan et al. (2004) Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival. Blood 103:3655-61
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Arndt, C A; Krailo, M D; Liu-Mares, W et al. (2001) Phase I study of CI-958 in children and adolescents with recurrent solid tumors. Cancer 91:1166-9
Adamson, P C; Widemann, B C; Reaman, G H et al. (2001) A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study. Clin Cancer Res 7:3034-9
Cooper, R; Khakoo, Y; Matthay, K K et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 36:623-9

Showing the most recent 10 out of 14 publications